CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
KSM-66 Ashwagandha +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07041853
NCT07041853N/ACompleted
CompareCT.gov

The Effects of KSM-66 Ashwagandha (Withania Somnifera) Supplementation on Recovery and Muscle Strength in Academy Athletes

University Ramon Llull·interventional·Posted Jun 27, 2025·Updated Sep 2, 2025

In Brief

A clinical study evaluating KSM-66 Ashwagandha and Placebo for Recovery and 2 related conditions. Completed, enrolled 56 participants across 1 site.

Detailed Summary

This double-blind, randomised, placebo-controlled trial will examine the effects of 42-day root extract ashwagandha (KSM-66) supplementation on recovery and muscle strength in male and female rugby and water polo players. Participants will receive either 600 mg of ashwagandha or a placebo daily. Outcomes include hormonal stress markers, perceived exertion, wellness, muscle soreness and strength and performance metrics (grip strength, jump tests, 1RM lifts, Bronco test).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecovery, Strength, Exercise Training
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedJun 27, 2025
Enrollment StartJun 12, 2025
Primary CompletionJul 31, 2025
Study CompletionAug 25, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.0 years ago

Interventions

KSM-66 Ashwagandhadietary

Root extract ashwagandha, KSM-66

Placebodietary

Organic chickpea flour